The WACC of NOXXON Pharma NV (ALNOX.PA) is 8.8%.
| Range | Selected | |
| Cost of equity | 7.30% - 10.30% | 8.80% |
| Tax rate | 29.80% - 31.80% | 30.80% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 7.3% - 10.3% | 8.8% |
| Category | Low | High |
| Long-term bond rate | 2.6% | 3.1% |
| Equity market risk premium | 5.2% | 6.2% |
| Adjusted beta | 0.9 | 1.08 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 7.30% | 10.30% |
| Tax rate | 29.80% | 31.80% |
| Debt/Equity ratio | 0 | 0 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 7.3% | 10.3% |
| Selected WACC | 8.8% | |